KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Operations: 2009-2025

Historic Cash from Operations for Thermo Fisher Scientific (TMO) over the last 16 years, with Sep 2025 value amounting to $2.2 billion.

  • Thermo Fisher Scientific's Cash from Operations rose 3.37% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.7 billion, marking a year-over-year decrease of 15.92%. This contributed to the annual value of $8.7 billion for FY2024, which is 3.10% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's Cash from Operations stood at $2.2 billion, which was up 60.04% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's Cash from Operations peaked at $3.7 billion during Q4 2023, and registered a low of $723.0 million during Q1 2025.
  • Moreover, its 3-year median value for Cash from Operations was $2.0 billion (2024), whereas its average is $1.9 billion.
  • In the last 5 years, Thermo Fisher Scientific's Cash from Operations skyrocketed by 455.62% in 2021 and then plummeted by 66.89% in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's Cash from Operations (Quarterly) stood at $2.5 billion in 2021, then skyrocketed by 41.92% to $3.5 billion in 2022, then climbed by 6.77% to $3.7 billion in 2023, then declined by 11.63% to $3.3 billion in 2024, then rose by 3.37% to $2.2 billion in 2025.
  • Its Cash from Operations was $2.2 billion in Q3 2025, compared to $1.4 billion in Q2 2025 and $723.0 million in Q1 2025.